Steven F. Kemeny is a notable inventor based in Philadelphia, PA, with a focus on pharmaceutical innovations. He holds a total of 7 patents that contribute significantly to the field of drug formulation and delivery systems. His work emphasizes the importance of creating medications that are both effective and safe for patients.

Latest Patents

Among his latest patents is the "Extended release abuse deterrent liquid fill dosage form." This invention relates to an oral, extended release dosage form that includes a controlled release agent and at least one active pharmaceutical ingredient susceptible to abuse. The formulation is designed to be stable at high temperatures and provides an abuse deterrent against oral and parenteral administration through various methods. Another significant patent is the "Extruded extended release abuse deterrent pill," which describes an oral pill containing a drug homogenously spread throughout a matrix. This pill can be produced using a hot melt extrusion process and meets regulatory guidelines for extended release formulations, ensuring it is also abuse deterrent.

Career Highlights

Steven Kemeny is associated with Pharmaceutical Manufacturing Research Services, Inc., where he applies his expertise in pharmaceutical development. His innovative approaches have led to advancements in the safety and efficacy of drug delivery systems.

Collaborations

He has collaborated with notable colleagues, including Edwin R. Thompson and Eric R. Thompson, to further enhance the impact of his inventions in the pharmaceutical industry.

Conclusion

Steven F. Kemeny's contributions to pharmaceutical innovations demonstrate his commitment to improving medication safety and effectiveness. His patents reflect a deep understanding of the challenges in drug formulation and a dedication to addressing them.

This text is generated by artificial intelligence and may not be accurate.